Business Daily Media

Men's Weekly

.

Zuellig Pharma and Institut AllergoSan sign 10-year regional partnership to bring leading probiotic brand OMNi-BiOTiC® to key markets in Asia

New agreement marks major milestone for Zuellig Pharma as it focuses on expanding its consumer healthcare segment, and for Institut AllergoSan as it expands its global presence

SINGAPORE - Media OutReach Newswire - 19 July 2024 - Zuellig Pharma, a leading healthcare solutions company in Asia, today announced that it has signed a 10-year commercialisation partnership with Austria-based Institut AllergoSan, a research and development company that specialises in products made from natural substances such as probiotic bacteria, plant extracts and minerals.

Anita Frauwallner, founder and CEO of Institut AllergoSan (left) and John Graham, Group CEO, Zuellig Pharma (right) at the partnership signing ceremony to bring OMNi-BiOTiC® to key markets in Asia.
Anita Frauwallner, founder and CEO of Institut AllergoSan (left) and John Graham, Group CEO, Zuellig Pharma (right) at the partnership signing ceremony to bring OMNi-BiOTiC® to key markets in Asia.

Under this partnership, Zuellig Pharma will provide a wide spectrum of commercialisation support, including product registration, sales and marketing, and warehousing and distribution services to bring OMNi-BiOTiC®, one of Institut AllergoSan's leading probiotic brands, to key markets in Asia.

"Our consumer healthcare segment will be one of the key growth drivers in our business over the coming years and this partnership represents a significant step forward in our commitment to delivering innovative and accessible healthcare solutions to patients in Asia. With a fast-growing probiotics market in Asia, the comprehensive and tailored solutions offered through our commercialisation division, ZP Therapeutics, will help our partners expand their footprint to meet greater consumer demand for gut health products in this region. Together with Institut AllergoSan, we will leverage our combined expertise to enhance the well-being of consumers and drive forward our mission of making healthcare more accessible," said John Graham, Group CEO, Zuellig Pharma.

"We are dedicated to supporting consumers' pursuit of a healthier, more vital self and offer medically relevant probiotic supplements that target specific health needs and deliver clinically backed results. OMNi-BiOTiC® is the top selling probiotic brand in all German-speaking markets in Europe such as Austria, Germany and Switzerland[1] and we look forward to working closely with Zuellig Pharma to bring these innovative products to everybody in Asia who wants to promote an active, healthy life," adds Anita Frauwallner, founder and CEO of Institut AllergoSan.

Zuellig Pharma plans to launch OMNi-BiOTiC® in Indonesia, the Philippines and Taiwan in 2025, followed by other key markets thereafter.


[1] IQVIA OTC Global Insights 2023, 03F1/A7F, IQVIA OTC Audits / Public Price in EUR.
Hashtag: #ZuelligPharma #InstitutAllergoSan #Healthcare #Probiotics #ConsumerHealthcare #GutHealth #Commercialisation



The issuer is solely responsible for the content of this announcement.

About Zuellig Pharma

Zuellig Pharma is a leading healthcare solutions company in Asia, and our mission is to make healthcare more accessible to the communities we serve. We provide world-class distribution, digital and commercial services to support the growing healthcare needs in this region. The company was started a hundred years ago and has grown to become a multi-billion dollar business covering 16 markets with over 12,000 employees. Our people serve more than 200,000 medical facilities and work with over 450 clients, including the top 20 pharmaceutical companies in the world.

ZP Therapeutics, a division of Zuellig Pharma, is the commercialisation partner of choice for the healthcare industry with offices in 13 countries across Asia and over 2,500 associates. A catalyst in improving patient journeys and healthcare outcomes through commercial excellence, robust in-market capabilities and strong ethical principles, ZP Therapeutics is a trusted partner for expanding patient access and providing innovations to the healthcare community.

For more information, visit:

About Institut AllergoSan

Institut AllergoSan, based in Graz, Austria, was founded in 1991 by a group of integrative doctors and pharmacists together with Anita Frauwallner, who is now the managing director. Since then, the company has been focused on the scientific research and development of products made from natural substances such as probiotic bacteria, dietary fibres, micronutrients, and plant extracts. Through the intensive cooperation between Institut AllergoSan and recognised scientists from the fields of medicine, pharmacy, and biochemistry, it has been possible to build up a recognised research and competence centre focused on the largest organ of the human body - the intestine. This has resulted in the OMNi-BiOTiC®, OMNi-LOGiC® and META-CARE® product range, among others.

It has been a true pioneering spirit that drove Anita Frauwallner to embark on a largely unknown path more than 30 years ago: she has dedicated her life to microbiome research and the development of innovative, high-quality probiotics. This spirit has brought OMNi-BiOTiC® to rank today as number 3 on the global probiotic market and number 1 in German-speaking Europe and numerous other countries.

News from Asia

Deleted

This Press release has been killed

Ausom Launches L1 ABE Electric Scooter with Full German Road Approval

HONG KONG SAR - Media OutReach Newswire - 15 October 2025 - Ausom’s new L1 ABE electric scooter is now available with full road approval in Germany—and for a limited time, it’s launching with spec...

Top Hong Kong Hotels 2025 | Regent Hong Kong Achieves Prestigious Recognition in Condé Nast Traveler Awards

HONG KONG / SINGAPORE - Media OutReach Newswire - 15 October 2025 - Regent Hong Kong proudly announces its recognition in the Condé Nast Traveler Readers' Choice Awards 2025 as one of the top 5 be...

OPPO ColorOS 16 Set for Global Unveil: A New Era of Smoothness, Intelligence, and Seamless Connectivity

SHENZHEN, CHINA - Media OutReach Newswire - 15 October 2025 - OPPO has revealed its first look at ColorOS 16, the latest version of its mobile operating system, launching with the upcoming Find X9...

Xsolla Brings Exclusive Event To Thailand With Xsolla Connect Bangkok: A Global Games Industry Gathering

Exclusive Event Brings Developers, Publishers, Investors, And Industry Leaders Together to Help Shape The Future Of Gaming BANGKOK, THAILAND - Media OutReach Newswire - 15 October 2025 - Xsolla, a...

APAC Employee Medical Plan Costs to Stabilise in 2026 After Two Years of Sharp Increase, Aon reports

China, India, Singapore, the Philippines and Vietnam projecting lower increases than previous year Cardiovascular diseases, gastrointestinal conditions and cancer are top medical ...

Singapore and Shanghai Professional Bodies Sign MOU to Empower Enterprises Through Cross-Border Collaboration

SINGAPORE - Media OutReach Newswire - 15 October 2025 – Professional and business communities from Singapore and Shanghai came together today in a landmark collaboration to deepen ties and empower...

Watch Exchange Turns Luxury Timepieces Into Hope: Charity Drive to Raise At Least S$100K for Elderly Care

"Give Time, Share Hope" campaign transforms dormant watches into tangible support for Geylang East Home for the Aged SINGAPORE - Media OutReach Newswire - 15 October 2025 – As Singapore's populati...

Coca-Cola: First in Hong Kong in Recycling Plastic Bottles to Create New Ones Leveraging Its Own Facilities

Continuing to advocate for and invest in well-designed collection systems to help reduce beverage packaging waste HONG KONG SAR - Media OutReach Newswire - 15 October 2025 - Coca-Cola in Hong Kong...

AIA survey: 72% of respondents lack sufficient retirement reserves 60% have yet to make advance preparations

Nearly 70% believe smart technology can help build better MPF portfolios AIA launches new MPF Smart Advisor to support members in achieving their desired retirement life HONG KONG SAR - Media Out...

Qantas to Serve Nan’s Davidson Plum Cookie

Lake Macquarie, NSW (Awabakal Country): From a single mother’s kitchen bench to supermarket shelves, Wiradjuri entrepreneur Terri-Ann “Tezzi” Dani...

Minns Labor Government shutting down the Business Connect program

The NSW Opposition is concerned that the Labor government will shut down a support program that has assisted New South Wales businesses. In a media ...

Samsara Eco appoints Dr. Lars Kissau as General Manager for Asia

Australian biotech innovator Samsara Eco has announced the appointment of Dr Lars Kissau as its first General Manager of Asia. Based in Singapore...

From the first bounce to the final siren - small business lessons from the AFL Grand Final

The AFL Grand Final is one of the most anticipated days on the sporting calendar. This Saturday, the Geelong Cats and Brisbane Lions will battle i...

Australia’s top finance leaders recognised as CFO role expands

Amid surging regulatory demands and rapidly evolving industry, Australia’s most influential Chief Financial Officers will be honoured at the inaug...

Why outdated security leaves small businesses exposed to crime

Small and medium businesses in Australia are under increasing pressure to address security gaps that criminals readily exploit. An unlocked door, an...